financetom
Business
financetom
/
Business
/
Ati Insider Sold Shares Worth $657,459, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ati Insider Sold Shares Worth $657,459, According to a Recent SEC Filing
Feb 7, 2025 2:51 PM

05:29 PM EST, 02/07/2025 (MT Newswires) -- Tina Killough Busch, Senior Vice President, Chief Human Resources Officer, on February 06, 2025, sold 9,900 shares in Ati (ATI) for $657,459. Following the Form 4 filing with the SEC, Busch has control over a total of 25,994 common shares of the company, with 25,994 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1018963/000095017025016453/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
eToro Posts 13% Increase in February Assets Under Administration
eToro Posts 13% Increase in February Assets Under Administration
Mar 11, 2026
09:44 AM EDT, 03/09/2026 (MT Newswires) -- eToro (ETOR) said Monday that its assets under administration increased by 13% year over year in February to $17.6 billion. Funded accounts for the month were 3.9 million, up 10% from a year earlier, the company said. Price: 31.94, Change: +0.12, Percent Change: +0.38 ...
Substantial share purchases by Burford executive officers
Substantial share purchases by Burford executive officers
Mar 11, 2026
NEW YORK, March 9, 2026 /PRNewswire/ -- Burford Capital Limited ( BUR ) (Burford or the Company), the leading global finance and asset management firm focused on law, provides the following notifications of various transactions by persons discharging managerial responsibilities (each, a PDMR), as well as a notification of its intention to purchase Burford's ordinary shares of nil par value...
AbbVie's Study of Weight-Loss Drug Outperforms Placebo
AbbVie's Study of Weight-Loss Drug Outperforms Placebo
Mar 11, 2026
09:50 AM EDT, 03/09/2026 (MT Newswires) -- AbbVie ( ABBV ) said Monday that topline results from the multiple ascending dose part of its phase 1 study of subcutaneous ABBV-295 to treat for chronic weight management showed the drug significantly outperformed placebo. The company said ABBV-295 demonstrated clinically meaningful, dose-dependent reductions in body weight over a 12-13-week period. It said...
Fireweed Metals Starts Mactung Tungsten Project Feasibility Study
Fireweed Metals Starts Mactung Tungsten Project Feasibility Study
Mar 11, 2026
09:41 AM EDT, 03/09/2026 (MT Newswires) -- Fireweed Metals ( FWEDF ) on Monday said it engaged a team of internationally recognized engineering and technical consultants with extensive project delivery and licensing experience in the Yukon and northern Canada to complete an updated Feasibility Study for its 100%-owned Mactung Tungsten project, located in Yukon, Canada. We are confident that with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved